Company Overview

Evolent Health, Inc. is a U.S.-based healthcare services and technology company focused on helping health plans, providers, and government-sponsored healthcare programs manage value-based care. The company operates primarily in the healthcare technology, specialty care management, and population health industries, supporting organizations that assume financial risk for patient outcomes and healthcare costs. Evolent’s core business model centers on administrative and clinical solutions that help payers and providers improve care quality while reducing medical expenses.

The company’s primary revenue drivers include specialty care management services, administrative platform services, and clinical solutions delivered through its operating segments and subsidiaries. Evolent has developed capabilities in oncology management, cardiology, musculoskeletal care, and surgical management through acquisitions and internal platform development. Originally founded in 2011 by leaders associated with The Advisory Board Company and UPMC Health Plan, Evolent evolved from a population health management company into a broader specialty-care and payer-services organization through acquisitions, strategic partnerships, and expansion into managed care support services.

Business Operations

Evolent generates revenue through healthcare management services provided to health plans, providers, and government-sponsored programs such as Medicare Advantage and Medicaid. Its operations historically included two major business areas: Evolent Care Partners and Evolent Health Services, though the company has increasingly emphasized specialty condition management and administrative infrastructure. Key subsidiaries and business units include New Century Health, focused on oncology and cardiology management, and NIA, a specialty benefits management business acquired from Magellan Health. These assets provide utilization management, clinical decision support, and specialty care coordination services.

The company operates primarily in the United States, serving national and regional health plans, provider organizations, and accountable care entities. Evolent’s technology infrastructure includes data analytics platforms, utilization management systems, and clinical workflow technologies used to coordinate care and manage medical costs. Strategic relationships with major insurers and provider systems have been important to its operating model. The company has also maintained partnerships tied to value-based care delivery and administrative outsourcing arrangements across commercial and government-sponsored healthcare markets.

Strategic Position & Investments

Evolent’s strategic direction has centered on expanding specialty care management capabilities and increasing recurring revenue from health plan clients. A significant component of this strategy has been acquisition-driven growth. The acquisition of New Century Health expanded Evolent’s oncology and cardiology management platform, while the purchase of NIA from Magellan Health materially increased the company’s specialty benefits management scale in radiology and musculoskeletal care. These transactions positioned Evolent as a larger participant in specialty cost management within U.S. healthcare.

The company has continued investing in data analytics, clinical automation, and value-based care enablement technologies intended to improve healthcare outcomes and reduce unnecessary utilization. Evolent’s business strategy also reflects broader healthcare industry trends toward risk-sharing arrangements and outsourced clinical management services. Public filings and investor materials indicate continued focus on Medicare Advantage, Medicaid managed care, and specialty utilization management as long-term growth areas. Data regarding material international investments or non-U.S. operating expansion is limited based on available public sources.

Geographic Footprint

Evolent Health is headquartered in Arlington, Virginia, and primarily operates across the United States. Its customer base includes national and regional health insurers, physician organizations, and healthcare systems serving patients in multiple U.S. markets. The company’s services are delivered through centralized technology and clinical operations supporting healthcare organizations nationwide.

While Evolent’s operational footprint is concentrated domestically, its influence extends broadly through contracts with multi-state health plans and provider networks. Public disclosures emphasize nationwide service capabilities rather than substantial direct international operations. Data inconclusive based on available public sources regarding meaningful standalone operational presence outside the United States.

Leadership & Governance

Evolent was co-founded by healthcare executives associated with The Advisory Board Company and UPMC Health Plan, including Frank Williams and Seth Blackley. The company’s leadership strategy has emphasized scaling specialty care management, expanding value-based care infrastructure, and supporting payer-provider collaboration in cost containment and clinical quality improvement. Governance and strategic priorities are guided through public-company reporting structures and board oversight consistent with listed healthcare technology firms.

Key executives include:

• Seth Blackley – Co-Founder and Chief Executive Officer
• John Johnson – President
• Mark Kenney – Chief Financial Officer
• Emily Ann Rafferty – Chief Operating Officer
• Erich Mounce – Chief Accounting Officer
• Frank Williams – Co-Founder and Executive Chair

Company leadership has consistently communicated a strategic focus on specialty cost management, operational efficiency, and long-term participation in the transition from fee-for-service reimbursement toward value-based healthcare delivery models, as reflected in public filings, earnings materials, and investor presentations.